Skip to main content

Advertisement

Log in

Radiographic changes in lung of patients treated with stereotactic ablative body radiation therapy: low-dose volumes as the driving force for radiographic change

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Objective

To describe radiographic evidence of radiation pneumonitis (rRP) and fibrosis (rRF) and determine what dosimetric parameters correlate with rRP and rRF after stereotactic ablative radiation therapy (SABR) to the lung.

Methods

Ninety-eight follow-up computed tomography (CT) scans from 32 patients treated by SABR were retrospectively reviewed for CT appearance of rRP and rRF determined by the Ikezoe (≤6 months) and Koenig (≥7 months) systems. The dosimetric correlations for rRP, rRF, and fibrotic volume were analyzed.

Results

There was a 55 % incidence of rRP and 59 % incidence of rRF with a median follow-up of 10 months. Only the low-dose parameters V 2.5, V 5, V 7, and V 10 (the volume of lung receiving more than 2.5, 5, 7, and 10 Gy of radiation, respectively) were correlated to the development of rRP (p < 0.05). No parameter correlated with rRF, but V 5, V 7, and V 10 trended toward significance. The absolute fibrotic volume was correlated with the planning target volume (p = 0.01) and V 7 (p = 0.02).

Conclusion

The development of rRP and the fibrotic volume after SABR was correlated with the volume of lung that received lower doses of radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O’Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC (2010) Non-small cell lung cancer. J Natl Comp Cancer Network: JNCCN 8(7):740–801

    CAS  Google Scholar 

  2. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75(3):677–682. doi:10.1016/j.ijrobp.2008.11.042

    Article  PubMed  Google Scholar 

  3. Linda A, Trovo M, Bradley JD (2011) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur J Radiol 79(1):147–154. doi:10.1016/j.ejrad.2009.10.029

    Article  PubMed  Google Scholar 

  4. Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69(1):77–85. doi:10.1016/j.lungcan.2009.09.006

    Article  PubMed  Google Scholar 

  5. Ikezoe J, Takashima S, Morimoto S, Kadowaki K, Takeuchi N, Yamamoto T, Nakanishi K, Isaza M, Arisawa J, Ikeda H, et al. (1988) CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 150(4):765–770

    Article  CAS  PubMed  Google Scholar 

  6. Koenig TR, Munden RF, Erasmus JJ, Sabloff BS, Gladish GW, Komaki R, Stevens CW (2002) Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 178(6):1383–1388

    Article  PubMed  Google Scholar 

  7. Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M (2007) Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 85(3):435–442. doi:10.1016/j.radonc.2007.10.044

    Article  PubMed  Google Scholar 

  8. Bradley J (2007) Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2(7 Suppl 3):S118–S124. doi:10.1097/JTO.0b013e318074e50c

    Article  PubMed  Google Scholar 

  9. Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S (2011) Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6(7):1221–1228. doi:10.1097/JTO.0b013e318219aac5

    Article  PubMed  Google Scholar 

  10. Kyas I, Hof H, Debus J, Schlegel W, Karger CP (2007) Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67(3):768–774. doi:10.1016/j.ijrobp.2006.08.066

    Article  PubMed  Google Scholar 

  11. Guckenberger M, Baier K, Polat B, Richter A, Krieger T, Wilbert J, Mueller G, Flentje M (2010) Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 97(1):65–70. doi:10.1016/j.radonc.2010.04.027

    Article  PubMed  Google Scholar 

  12. Palma DA, van Sornsen de Koste J, Verbakel WF, Vincent A, Senan S (2010) Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2010.07.025

    Google Scholar 

  13. Prendergast BM, Bonner JA, Popple RA, Spencer SA, Fiveash JB, Keene KS, Cerfolio RJ, Minnich DJ, Dobelbower MC (2011) Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy. J Med Imaging Radiat Oncol 55(1):90–96. doi:10.1111/j.1754-9485.2010.02234.x

    Article  PubMed  Google Scholar 

  14. Aoki T, Nagata Y, Negoro Y, Takayama K, Mizowaki T, Kokubo M, Oya N, Mitsumori M, Hiraoka M (2004) Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 230(1):101–108. doi:10.1148/radiol.2301021226

    Article  PubMed  Google Scholar 

  15. Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M (2013) Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy. Med Phys 40(8):081712. doi:10.1118/1.4813916

    Article  PubMed  Google Scholar 

  16. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK (2003) Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55(3):724–735

    Article  PubMed  Google Scholar 

  17. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC (2005) Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63(3):672–682. doi:10.1016/j.ijrobp.2005.03.026

    Article  PubMed  Google Scholar 

  18. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B (2005) Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61(2):318–328. doi:10.1016/j.ijrobp.2004.06.260

    Article  PubMed  Google Scholar 

  19. Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M (2012) Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys 84(4):1024–1030. doi:10.1016/j.ijrobp.2011.11.080

    Article  PubMed  Google Scholar 

  20. Kimura T, Matsuura K, Murakami Y, Hashimoto Y, Kenjo M, Kaneyasu Y, Wadasaki K, Hirokawa Y, Ito K, Okawa M (2006) CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 66(2):483–491. doi:10.1016/j.ijrobp.2006.05.008

    Article  PubMed  Google Scholar 

  21. Ghobadi G, Hogeweg LE, Faber H, Tukker WG, Schippers JM, Brandenburg S, Langendijk JA, Coppes RP, van Luijk P (2010) Quantifying local radiation-induced lung damage from computed tomography. Int J Radiat Oncol Biol Phys 76(2):548–556. doi:10.1016/j.ijrobp.2009.08.058

    Article  PubMed  Google Scholar 

  22. Chi A, Wen S, Liao Z, Fowler J, Xu J, Nguyen NP, Welsh JS, Komaki R (2013) What would be the most appropriate alpha/beta ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. BioMed Res Int 2013:391021. doi:10.1155/2013/391021

    PubMed  PubMed Central  Google Scholar 

  23. Guckenberger M, Klement RJ, Allgauer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109(1):13–20. doi:10.1016/j.radonc.2013.09.005

    Article  PubMed  Google Scholar 

  24. Casamassima F, Masi L, Bonucci I, Polli C, Menichelli C, Gulisano M, Pacini S, Aterini S, Cavedon C (2008) Relevance of biologically equivalent dose values in outcome evaluation of stereotactic radiotherapy for lung nodules. Int J Radiat Oncol Biol Phys 71(1):145–151. doi:10.1016/j.ijrobp.2007.09.036

    Article  PubMed  Google Scholar 

  25. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952. doi:10.1200/jco.2006.09.7469

    Article  PubMed  Google Scholar 

  26. Hof H, Zgoda J, Nill S, Hoess A, Kopp-Schneider A, Herfarth K, Debus J, Plathow C (2010) Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 77(5):1369–1374. doi:10.1016/j.ijrobp.2009.06.082

    Article  PubMed  Google Scholar 

  27. Komaki R, Travis E, Cox J (2010) The lung, pleura, and thymus. In: Cox J, Ang K (eds) Radiation oncology: rationale, technique. Results. Ninth edn. Mosby, Inc., Philadelphia, PA, p. 425

    Google Scholar 

  28. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33(1):99–109

    Article  CAS  PubMed  Google Scholar 

  29. Senthi S, Dahele M, van de Ven PM, Slotman BJ, Senan S (2013) Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques. Radiother Oncol 109(1):77–81. doi:10.1016/j.radonc.2013.08.034

    Article  PubMed  Google Scholar 

  30. Yang M, Zhang L, Bi N, Ji W, Tan W, Zhao L, Yu D, Wu C, Wang L, Lin D (2011) Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 79(5):1402–1407. doi:10.1016/j.ijrobp.2009.12.042

    Article  CAS  PubMed  Google Scholar 

  31. Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, Komaki R, Gomez D, Wang LE, Wei Q (2013) ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 85(4):1066–1073. doi:10.1016/j.ijrobp.2012.09.024

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Park.

Ethics declarations

Funding

There were no sources of funding for this project.

Conflict of interest statements

John Park does not have any conflict of interests to report.

Saikat Das does not have any conflict of interests to report.

Bruce F. Kimler does not have any conflict of interests to report.

Rajeev Badkul does not have any conflict of interests to report.

Nicole Nolan does not have any conflict of interests to report.

Parvesh Kumar does not have any conflict of interests to report.

Glendon Cox does not have any conflict of interests to report.

Fen Wang does not have any conflict of interests to report.

Ethical standards

This article does not contain any studies with human or animal subjects performed by any of the authors. All patient information was collected on an Institutional Review Board and Human Subjects Committee approved study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, J., Das, S., Kimler, B.F. et al. Radiographic changes in lung of patients treated with stereotactic ablative body radiation therapy: low-dose volumes as the driving force for radiographic change. J Radiat Oncol 5, 265–272 (2016). https://doi.org/10.1007/s13566-016-0254-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-016-0254-7

Keywords

Navigation